Form 4 for PPCB Propanc Biopharma, Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-17 · accession 0001493152-21-020758 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-08-20 | 2021-08-17 | PPCB | Nathanielsz James Andrew | CEO, CFO, Dir | A - Grant | $0.00 | +8.73M | 2.80M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2021-08-17 | A | A | 5,928,000 | $0.00 | 5,928,004 | I North Horizon Investments Pty Ltd. as Trustee for Nathanielsz Family Trust | — | — | |
| 2 | Common | Common stock, par value $0.001 | 2021-08-17 | A | A | 2,800,000 | $0.00 | 2,800,000 | I By Spouse | — | — |